Should Faster Rapid-Acting Insulins be the standard for first line therapy?

Eli Lilly and Company |
Monday

Chair: Partha Kar (UK)

17:00 – 18:00Should Faster Rapid-Acting Insulins be the standard for first line therapy?Matthias Weber (GER)
Thomas Haak (GER)
Partha Kar (UK)
Emma Wilmot (UK)